| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,256 | 1,258 | 1,000 | 338 | | Cost of Revenue | 5 | 8 |
-
| 447 | | | Gross Profit | 1,251 | 1,250 | 1,000 | (109) | | | Operating Expenses | | Research Development | 837 | 2,015 | 108 | 70 | | Selling General and Administrative | 1,490 | 1,678 | 4,768 | 1,868 | | Non Recurring |
-
|
-
| (3) | 70 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,076) | (2,443) | (3,873) | (2,117) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 35 | 49 | 34 | 8 | | Earnings Before Interest And Taxes | (1,041) | (2,394) | (3,839) | (2,109) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,041) | (2,394) | (3,839) | (2,109) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,041) | (2,394) | (3,839) | (2,109) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,041) | (2,394) | (3,839) | (2,109) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,041) | ($2,394) | ($3,839) | ($2,109) |
|
0.51% Nasdaq 
Income Statement
